Larta's 2009 Life Sciences Venture Forum - without peer
A stand-out event for interesting times...

For many, it was simply the best Forum ever. Certainly, it was the most intimate, the most interactive, the most spirited one that we have presented. Hard-hitting, expansive panels offered insights worthy of a high-powered event. High-quality presentations from stellar entrepreneurs again showed why the Forum is the best platform to showcase the most innovative offerings from the minds of emerging innovators. All of this, and active, constant networking, helps explain why our Life Sciences Venture Forum is worth the wait, year after year.

	Opening keynote - Dr. Richard N. Foster, Millbrook Management Group
	Keynote conversation between Ed Penhoet, Ph.D., Gordon & Betty Moore Foundation and Matthew Bishop, The Economist
	Town Hall Forum: Post Stimulus Response
	Panel - Novel Product Development Approaches

Visit www.theventureforum.com to view pictures, company presentations.

R&D Tax Credit – A Useful Cash Strategy
Stephen M. Ragow, National Managing Director - MJF, LLP

Finding sources of revenue and/or cutting costs are major tasks in any business operation - especially today. Often times, either in period of booms and or crunch time, some very simple and available opportunities get overlooked or are casually glanced over with the result being more of a significant loss to the operation. One such opportunity is the Research and Development Tax Credit. In 2001, the Bush administration enhanced tax incentives, such as the R&D tax credit, in order to help small and mid-market companies compete globally. Read more ...

Venture capitalist confidence up, still wary: survey
David Lawsky - Reuters

Venture capitalists believe the worst of the financial crisis is behind them but are not expecting a rapid recovery in initial public offerings and deals this year, a quarterly survey released on Wednesday showed.

Of the 42 venture capitalists who responded to a survey for this quarter's Silicon Valley Venture Capitalist Confidence Index, some expected a gradual resumption of M&A, investment and initial share float activity in the second half. Read more ...

American Recovery & Reinvestment Act Update

NIH SBIR grantees are now eligible to apply for the two new Funding Opportunity Announcements (FOAS) that will be supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”):

Click here for more information. Application submission is due September 1, 2009.

Commercialization & IP Protection Webinar

Throughout July and August, Larta sponsor WilmerHale, will offer 2008/2009 NIH Commercialization Assistance Program (CAP) participants 3 webinars focused on early stage commercialization and IP protection. These seminars are specifically designed for CAP participating companies and provide the most up-to-date information on strategic intellectual property protection and planning practices relevant to small businesses. These customized web seminars are developed for the CAP to further companies' commercialization goals. WilmerHale representatives Dr. Jane Love and Nader Mousavi will provide tips for establishing strategic intellectual property protection and planning as well as commercialization and planning. These webinars will also cover both “best practices” and “traps for the wary” in these key areas.

Our picks of Larta-alumni companies that are making the news and already on their way to making it big!

2008-2009 NIH Commercialization Assistance Program (CAP) participant iVisit has recently received the 2009 E-tech Award for Healthcare Solutions for it's iVisit RX technology.

iVisit Rx is a platform for enabling healthcare organizations to deploy scalable telehealth and assisted living solutions. The technology combines audio-video conferencing, instant photo sharing, push-to-talk, instant messaging, remote patient monitoring, session recording for medical records and GPS location-based-services into a powerful unified communications tool. It works across IP and 3G+ networks and allows connectivity between mobile phones, computers, and mobile diagnostic devices.

The technology enables face-to-face communication between medical practitioners and patients, allowing for remote patient treatment and monitoring. It also can be used for monitoring drug therapy and compliance, reinforcing nutritional guidelines, and ensuring patients stick to a treatment program.

2008-2009 NIH Commercialization Assistance Program (CAP) participant, Fairway Medical Technologies received Frost & Sullivan, the Growth Partnership Company, 2009 Excellence in Medical Technologies & Life Sciences Award

Fairway is a fully integrated medical device developer and manufacturer with experience to bring ideas to the market place. Out NIH sponsored technology is the optoacoustic tomography, a fusion of optical and ultrasound imaging that provides two- and three-dimensional images of tissues based mainly on distribution of blood. Applications of this platform technology are numerous and include cancer detection and diagnostics, characterization of tissue blood concentration and its oxygen saturation, differentiation of vulnerable arterial plaque and others.

BioExec Institute

In a volatile economy, it is more important than ever to understand core business decisions in BioPharma. The BioExec Institute focuses on management decision-making in a complex R&D, operational, regulatory and market environment. Join other managers at BioExec Institute 2009 to debate and discuss the business, issues and trends facing BioPharma.

This Institute is the only Executive Education series specifically designed to discuss business strategies with key leaders who have provided unique value to the industry.

Co-produced by UC Berkeley, Deloitte and Prescience Intl, the BioExec Institute brings together director and VP-level management for this six-day interactive program [3 modules of 2 days each]. For more information or to register, visit http://www.prescienceintl.com/bioexec.html.

5th Germany California Solar Day
Tuesday, June 16, 2009
PG&E Auditorium, 245 Market Street, San Francisco, CA

The German American Chamber of Commerce Inc., California Branch (GACC), will hold its “5th Germany California Solar Day,” a highly successful bilateral platform for U.S. and German businesses to exchange the latest knowledge, thoughts and trends in the solar power industry with the goal of fostering successful transatlantic business partnerships. German and American expert speakers will discuss the newest solar power industry developments during the first half of the conference. In the afternoon, the German companies will have a chance to present their products and services to the audience. The day will conclude with a Networking Reception and a B2B Meeting Forum. Please visit www.gaccsanfrancisco.com for more information.

Going Green West
September 14-16, 2009 – Cavallo Point, Sausalito, CA

GoingGreen is where cutting-edge greentech CEOs meet the movers and shakers from the biggest industries on earth. Green technology innovators are transforming trillion dollar industries - and the solutions they are delivering not only promise to clean up pollution and restore ecosystems, but also to bring abundance and prosperity to everyone on earth. In fundamental areas, water, energy and land, resource abundance is just around the corner, through the power of technology and free markets. This two-and-a-half-day executive event features CEO presentations and high-level debates on the most promising emerging green technologies and new entrepreneurial opportunities. At GoingGreen, our editors will also honor the GoingGreen 100 Top Private Companies. Fifty of the top CEOs from the GoingGreen 100 will pitch their market strategies to a panel of industry experts in our "CEO Showcase." For more information please visit alwayson.goingon.com

Visit our Events Calendar for a list of Larta's partners events.